story of the week
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
N. Engl. J. Med 2021 Sep 18;[EPub Ahead of Print], N Colombo, C Dubot, D Lorusso, MV Caceres, K Hasegawa, R Shapira-Frommer, KS Tewari, P Salman, E Hoyos Usta, E Yañez, M Gümüş, M Olivera Hurtado de Mendoza, V Samouëlian, V Castonguay, A Arkhipov, S Toker, K Li, SM Keefe, BJ MonkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.